Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma

NCT00844883 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Hepatoma

Interventions

DRUG: sorafenib
PROCEDURE: LC Bead-TACE

Sponsor

Yale University

Collaborators

[object Object]
[object Object]